- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/68 - Halogen atoms
Patent holdings for IPC class C07D 233/68
Total number of patents in this class: 107
10-year publication summary
|
9
|
9
|
7
|
10
|
5
|
9
|
6
|
3
|
2
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| VALO Health, Inc. | 195 |
6 |
| BASF SE | 21320 |
5 |
| TES Pharma S.r.l. | 20 |
5 |
| University of Tennessee Research Foundation | 765 |
5 |
| Bayer Pharma AG | 1005 |
4 |
| Georgia Tech Research Corporation | 2977 |
4 |
| Takeda Pharmaceutical Company Limited | 2700 |
4 |
| Theravance, Inc. | 61 |
4 |
| Genentech, Inc. | 4132 |
3 |
| E. I. du Pont de Nemours and Company | 3460 |
3 |
| Bayer AG | 3553 |
3 |
| Bayer Cropscience AG | 1830 |
3 |
| Nippon Soda Co., Ltd. | 884 |
3 |
| Shanghai Allist Pharmaceuticals, Inc. | 20 |
3 |
| Tokyo Ohka Kogyo Co., Ltd. | 1556 |
3 |
| Xenon Pharmaceuticals Inc. | 194 |
3 |
| Xiamen Vivohealths Technology Co., Ltd. | 7 |
3 |
| Tsinghua University | 6248 |
2 |
| Mitobridge, Inc. | 31 |
2 |
| Innate Tumor Immunity, Inc. | 40 |
2 |
| Other owners | 37 |